[(3-Methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl)-methylamino]oxymethyl acetate
| Internal ID | 7c6c9d47-8133-4a38-8198-c0a48030f4d5 |
| Taxonomy | Organoheterocyclic compounds > Indoles and derivatives > Carbazoles > Pyrrolocarbazoles > Indolocarbazoles |
| IUPAC Name | [(3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl)-methylamino]oxymethyl acetate |
| SMILES (Canonical) | CC(=O)OCON(C)C1CC2N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N(C7=C53)C(C1OC)(O2)C)CNC6=O |
| SMILES (Isomeric) | CC(=O)OCON(C)C1CC2N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N(C7=C53)C(C1OC)(O2)C)CNC6=O |
| InChI | InChI=1S/C31H30N4O6/c1-16(36)39-15-40-33(3)22-13-23-34-20-11-7-5-9-17(20)25-26-19(14-32-30(26)37)24-18-10-6-8-12-21(18)35(28(24)27(25)34)31(2,41-23)29(22)38-4/h5-12,22-23,29H,13-15H2,1-4H3,(H,32,37) |
| InChI Key | BFRBLQYPYHCFPY-UHFFFAOYSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C31H30N4O6 |
| Molecular Weight | 554.60 g/mol |
| Exact Mass | 554.21653469 g/mol |
| Topological Polar Surface Area (TPSA) | 96.20 Ų |
| XlogP | 3.70 |
| Atomic LogP (AlogP) | 4.52 |
| H-Bond Acceptor | 9 |
| H-Bond Donor | 1 |
| Rotatable Bonds | 5 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.6873 | 68.73% |
| Caco-2 | - | 0.7472 | 74.72% |
| Blood Brain Barrier | + | 0.5750 | 57.50% |
| Human oral bioavailability | - | 0.5857 | 58.57% |
| Subcellular localzation | Lysosomes | 0.5171 | 51.71% |
| OATP2B1 inhibitior | - | 0.7216 | 72.16% |
| OATP1B1 inhibitior | + | 0.8425 | 84.25% |
| OATP1B3 inhibitior | + | 0.9300 | 93.00% |
| MATE1 inhibitior | - | 0.7400 | 74.00% |
| OCT2 inhibitior | - | 0.8359 | 83.59% |
| BSEP inhibitior | + | 0.9938 | 99.38% |
| P-glycoprotein inhibitior | + | 0.8924 | 89.24% |
| P-glycoprotein substrate | + | 0.8836 | 88.36% |
| CYP3A4 substrate | + | 0.7342 | 73.42% |
| CYP2C9 substrate | - | 0.6083 | 60.83% |
| CYP2D6 substrate | - | 0.8802 | 88.02% |
| CYP3A4 inhibition | + | 0.8825 | 88.25% |
| CYP2C9 inhibition | - | 0.5952 | 59.52% |
| CYP2C19 inhibition | - | 0.6211 | 62.11% |
| CYP2D6 inhibition | - | 0.8287 | 82.87% |
| CYP1A2 inhibition | - | 0.8118 | 81.18% |
| CYP2C8 inhibition | + | 0.7410 | 74.10% |
| CYP inhibitory promiscuity | + | 0.6820 | 68.20% |
| UGT catelyzed | - | 0.0000 | 0.00% |
| Carcinogenicity (binary) | - | 0.8100 | 81.00% |
| Carcinogenicity (trinary) | Non-required | 0.5410 | 54.10% |
| Eye corrosion | - | 0.9838 | 98.38% |
| Eye irritation | - | 0.9504 | 95.04% |
| Skin irritation | - | 0.7757 | 77.57% |
| Skin corrosion | - | 0.9324 | 93.24% |
| Ames mutagenesis | + | 0.5646 | 56.46% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.8733 | 87.33% |
| Micronuclear | + | 0.7800 | 78.00% |
| Hepatotoxicity | + | 0.6698 | 66.98% |
| skin sensitisation | - | 0.8626 | 86.26% |
| Respiratory toxicity | + | 0.8444 | 84.44% |
| Reproductive toxicity | + | 0.8889 | 88.89% |
| Mitochondrial toxicity | + | 0.8250 | 82.50% |
| Nephrotoxicity | + | 0.5425 | 54.25% |
| Acute Oral Toxicity (c) | III | 0.5735 | 57.35% |
| Estrogen receptor binding | + | 0.7924 | 79.24% |
| Androgen receptor binding | + | 0.7015 | 70.15% |
| Thyroid receptor binding | + | 0.6843 | 68.43% |
| Glucocorticoid receptor binding | + | 0.8596 | 85.96% |
| Aromatase binding | + | 0.7276 | 72.76% |
| PPAR gamma | + | 0.6975 | 69.75% |
| Honey bee toxicity | - | 0.7084 | 70.84% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | - | 0.5300 | 53.00% |
| Fish aquatic toxicity | + | 0.7869 | 78.69% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.50% | 96.09% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 99.49% | 85.14% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.77% | 91.11% |
| CHEMBL2708 | Q16584 | Mitogen-activated protein kinase kinase kinase 11 | 98.72% | 81.14% |
| CHEMBL4924 | Q9UK32 | Ribosomal protein S6 kinase alpha 6 | 98.49% | 80.00% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 97.83% | 94.45% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 97.76% | 80.71% |
| CHEMBL5408 | Q9UHD2 | Serine/threonine-protein kinase TBK1 | 97.36% | 90.48% |
| CHEMBL5600 | P27448 | Serine/threonine-protein kinase c-TAK1 | 96.91% | 88.81% |
| CHEMBL2801 | Q13557 | CaM kinase II delta | 96.79% | 84.49% |
| CHEMBL2553 | Q15418 | Ribosomal protein S6 kinase alpha 1 | 96.78% | 85.11% |
| CHEMBL4598 | Q13043 | Serine/threonine-protein kinase MST1 | 96.38% | 96.64% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 96.15% | 83.10% |
| CHEMBL2581 | P07339 | Cathepsin D | 96.07% | 98.95% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 95.89% | 89.00% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 95.45% | 87.16% |
| CHEMBL2345 | P51812 | Ribosomal protein S6 kinase alpha 3 | 95.44% | 95.64% |
| CHEMBL5284 | Q96RR4 | CaM-kinase kinase beta | 95.02% | 89.23% |
| CHEMBL2964 | P36507 | Dual specificity mitogen-activated protein kinase kinase 2 | 94.93% | 80.00% |
| CHEMBL4578 | Q14680 | Maternal embryonic leucine zipper kinase | 94.86% | 81.58% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 94.59% | 95.56% |
| CHEMBL3788 | O00444 | Serine/threonine-protein kinase PLK4 | 93.41% | 83.65% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 93.30% | 90.08% |
| CHEMBL4237 | O75582 | Ribosomal protein S6 kinase alpha 5 | 92.28% | 91.00% |
| CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 92.23% | 94.00% |
| CHEMBL5678 | P34947 | G protein-coupled receptor kinase 5 | 92.13% | 88.00% |
| CHEMBL4895 | P30530 | Tyrosine-protein kinase receptor UFO | 91.95% | 90.95% |
| CHEMBL4599 | Q07912 | Tyrosine kinase non-receptor protein 2 | 91.94% | 94.29% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 91.91% | 95.89% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 91.77% | 86.33% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 91.76% | 97.25% |
| CHEMBL1974 | P36888 | Tyrosine-protein kinase receptor FLT3 | 91.46% | 91.83% |
| CHEMBL2041 | P07949 | Tyrosine-protein kinase receptor RET | 91.20% | 91.79% |
| CHEMBL1868 | P17948 | Vascular endothelial growth factor receptor 1 | 89.05% | 96.47% |
| CHEMBL5314 | Q06418 | Tyrosine-protein kinase receptor TYRO3 | 89.03% | 96.00% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 87.68% | 98.59% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 87.47% | 95.83% |
| CHEMBL2716 | Q8WUI4 | Histone deacetylase 7 | 87.41% | 89.44% |
| CHEMBL2996 | Q05655 | Protein kinase C delta | 87.12% | 97.79% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 86.80% | 97.09% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 86.05% | 93.00% |
| CHEMBL4224 | P49759 | Dual specificty protein kinase CLK1 | 85.58% | 85.30% |
| CHEMBL2007 | P16234 | Platelet-derived growth factor receptor alpha | 85.54% | 91.07% |
| CHEMBL3192 | Q9BY41 | Histone deacetylase 8 | 84.73% | 93.99% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 84.72% | 93.03% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 84.56% | 88.56% |
| CHEMBL3820 | P35557 | Hexokinase type IV | 84.11% | 91.96% |
| CHEMBL2094127 | P06493 | Cyclin-dependent kinase 1/cyclin B | 84.07% | 96.00% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 83.96% | 97.14% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 83.50% | 99.23% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 83.42% | 91.03% |
| CHEMBL2373 | P21730 | C5a anaphylatoxin chemotactic receptor | 82.22% | 92.62% |
| CHEMBL2803 | P43403 | Tyrosine-protein kinase ZAP-70 | 82.05% | 82.50% |
| CHEMBL2095226 | P05556 | Integrin alpha-5/beta-1 | 80.42% | 96.39% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 85149071 |
| LOTUS | LTS0160104 |
| wikiData | Q103816715 |